# Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine

> **NCT01548326** · PHASE4 · UNKNOWN · sponsor: **Nematollah Jonaidi Jafari** · enrollment: 52 (estimated)

## Conditions studied

- Hepatitis B
- Vaccination Failure

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01548326
- **Lead sponsor:** Nematollah Jonaidi Jafari
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2012-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548326, "Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01548326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*